An integrative model on the role of DMBT1 in epithelial cancer

Cancer Detection and Prevention

Volumn 26, Issue 4, 2002, Pages 266-274

  Mollenhauer, Jan ^a   Helmke, Burkhard ^b   Müller, Hanna ^a   Kollender, Gaby ^a   Krebs, Inge ^a   Wiemann, Stefan ^a   Holmskov, Uffe ^c   Madsen, Jens ^c   Otto, Herwart F ^b   Poustka, Annemarie ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

DMBT1; Glycoprotein 340; Mucin; Salivary agglutinin; Tumor suppressor

Indexed keywords

AGGLUTININ; CELL SURFACE RECEPTOR; DMBT1 PROTEIN, HUMAN;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; CELL CULTURE; CHROMOSOME MAP; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; HETEROZYGOSITY LOSS; HUMAN; METABOLISM; MOLECULAR GENETICS; NEOPLASM; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; VARIABLE NUMBER OF TANDEM REPEAT;

AGGLUTININS; AMINO ACID SEQUENCE; CARCINOMA, SQUAMOUS CELL; CHROMOSOME MAPPING; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LOSS OF HETEROZYGOSITY; MINISATELLITE REPEATS; MOLECULAR SEQUENCE DATA; NEOPLASMS, GLANDULAR AND EPITHELIAL; ORGAN SPECIFICITY; RECEPTORS, CELL SURFACE; TUMOR CELLS, CULTURED;

EID: 0036996464     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-090X(02)00094-6     Document Type: Article

References (25)

1. Mollenhauer J, Wiemann S, Scheurlen W, et al. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumors. Nat Genet 1997;17:32-9.
2. Mori M, Shiraishi T, Tanaka S, et al. Lack of DMBT1 expression in oesophageal, gastric and colon cancers. Br J Cancer 1999;79:211-3.
3. Takeshita H, Sato M, Shiwaku HO, et al. Expression of the DMBT1 gene is frequently suppressed in human lung cancer. Jpn J Cancer Res 1999;90:903-8.
4. Wu W, Kemp BL, Proctor ML, et al. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer. Cancer Res 1999;59:1846-51.
5. Somerville RPT, Shoshan Y, Eng C, et al. Molecular analysis of two putative tumour suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiform disease progression. Oncogene 1998;17:1755-7.
6. Petersen S, Rudolf J, Bockmühl U, et al. Analysis of the DMBT1 gene in carcinomas of the respiratory tract. Int J Cancer 2000;88:71-6.
7. Holmskov U, Mollenhauer J, Madsen J, et al. Cloning of gp-340 a putative opsonin receptor for lung surfactant protein D. Proc Natl Acad Sci USA 1999;96:10794-9.
8. Mollenhauer J, Herbertz S, Holmskov U, et al. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. Cancer Res 2000;60:1704-10.
9. Mollenhauer J, Herbertz S, Helmke B, et al. Deleted in malignant brain tumors 1 is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer. Cancer Res 2001;61:8880-6.
10. Mollenhauer J, Helmke B, Müller H, et al. Sequential changes of the DMBT1 expression and location in normal lung tissue and lung carcinomas. Genes Chromosomes Cancer, in press.
11. Mollenhauer J, Müller H, Kollender G, et al. The SRCR/SID region of DMBT1 defines a complex multi-allele system representing the major basis for its variability in cancer. Genes Chromosomes Cancer, in press.
12. Mollenhauer J, Holmskov U, Wiemann S, et al. The genomic structure of the DMBT1 gene: evidence for a region with susceptibility to genomic instability. Oncogene 1999;18:6233-40.
13. Prakobphol A, Xu F, Hoang VM, et al. Salivary agglutinin, which binds Streptococcus mutans and Helicobacter pylori, is the lung scavenger receptor cysteine-rich protein gp-340. J Biol Chem 2000;275:39860-6.
14. Ligtenberg TJ, Bikker FJ, Groenink J, et al. Human salivary agglutinin binds to lung surfactant protein D and is identical with scavenger receptor protein gp-340. Biochem J 2001;359:243-8.
15. Vijayakumar S, Takito J, Hikita C, et al. Hensin remodels the apical cytoskeleton and induces columnarization of intercalated epithelial cells: processes that resemble terminal differentiation. J Cell Biol 1999;144:1057-67.
16. Hikita C, Vijayakumar S, Takito J. et al. Induction of terminal differentiation in epithelial cells requires polymerization of hensin by galectin-3A. J Cell Biol 2000;151:1235-46.
17. Fornarini B, Iacobelli S, Tinari N, et al. Human milk 90K (Mac-2 bp); possible protective effects against acute respiratory infections. Clin Exp Immunol 1999;115:91-4.
18. Ullrich A, Sures I, D'Egidio M, et al. The secreted tumor-associated antigen 90K is a potent immune stimulator. J Biol Chem 1994;269:18401-7.
19. Jallal B, Powell J, Zachwieja J, et al. Suppression of tumor growth in vivo by local and systemic 90K level increase. Cancer Res 1995;55:3223-7.
20. Sasaki T, Brakebush C, Engel J, et al. Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds β1 integrins, collagens and fibronectin. EMBO J 1998;17:1606-13.
21. Nunes DP, Keates AC, Afdhal NH, et al. Bovine gallbladder mucin contains two distinct tandem repeating sequences: evidence for scavenger receptor cysteine-rich repeats. Biochem J 1995;310:41-8.
22. Takito J, Yan L, Hikita C, et al. Hensin, the polarity reversal protein, is encoded by DMBT1, a gene frequently deleted in malignant gliomas. Am J Physiol 1999;277:F277-89.
23. Corfield AP, Myerscough N, Longman R, et al. Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut 2000;47:589-94.
24. van Klinken BJW, Dekker J, Büller HA, et al. Mucin gene structure and expression: protection versus adhesion. Am J Physiol 1995;269:G613-27.
25. Hudson MJ, Stamp GW, Chaudhary KS, et al. Human MUC1 mucin: a potent glandular morphogen. J Pathol 2001;194:373-83.